kiovig
takeda manufacturing austria ag - humani normalni imunoglobulin (ivig) - purpura, thrombocytopenic, idiopathic; bone marrow transplantation; immunologic deficiency syndromes; guillain-barre syndrome; mucocutaneous lymph node syndrome - imunski sera in imunoglobulini, - nadomestno zdravljenje pri odraslih in otrok in mladostnikov (0-18 let): primarne imunske pomanjkljivosti sindromov s slabšo proizvodnjo protiteles;hypogammaglobulinaemia in ponavljajoče se bakterijske okužbe pri bolnikih s kronično limfocitno levkemijo, pri katerih profilaktičnih antibiotikov ni uspelo;hypogammaglobulinaemia in ponavljajoče se bakterijske okužbe v planota-faza-več-plazmocitom bolnikih, ki so se odzvali na pnevmokokna imunizacijo;hypogammaglobulinaemia pri bolnikih po allogeneic haematopoietic-matičnih-celic presaditev (hsct);prirojene pomoČi in ponavljajoče se bakterijske okužbe. immunomodulation pri odraslih in otrok in mladostnikov (0-18 let) v:primarna imunska trombocitopenija (itp), pri bolnikih z visokim tveganjem za krvavitve ali pred operacijo, da se popravi trombocitov štetje;guillain barré sindrom;kawasaki bolezni;multifokalna motornih nevropatija (mmn).
vpriv
takeda pharmaceuticals international ag ireland branch - velagluceraza alfa - gaucher bolezen - drugi zdravljene bolezni prebavil in presnove izdelki, - vpriv je indiciran za dolgoročno encimsko nadomestno zdravljenje (ert) pri bolnikih z gaucherjevo boleznijo tipa 1.
tachosil
corza medical gmbh - humani fibrinogen, humani trombin - hemostaz, kirurški - antihemoragije - tachosil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient. tachosil is indicated in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery (see section 5.
revestive
takeda pharmaceuticals international ag ireland branch - teduglutid - malabsorpcijski sindromi - drugi zdravljene bolezni prebavil in presnove izdelki, - revesiven je indiciran za zdravljenje bolnikov, starih 1 leto in več, s kratkim bowelovim sindromom (sbs). bolniki morajo biti po obdobju kirurške prilagoditve črevesja stabilni. revestive je indiciran za zdravljenje bolnikov, starih 1 leto in več s kratkimi Črevesja. bolniki morajo biti po obdobju kirurške prilagoditve črevesja stabilni.
vipdomet
takeda pharma a/s - alogliptin benzoata, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. trojna kombinacija terapija), kot dodatek k prehrani in vadbi za izboljšanje glycaemic nadzor pri bolnikih, pri insulina na stabilen odmerek in metforminom sam ne zagotavljajo ustrezne glycaemic nadzor.
natpar
takeda pharmaceuticals international ag ireland branch - obščitnični hormon - hipopatriroidizem - kalcij homeostaza - natpar je indiciran kot dodatno zdravljenje odraslih bolnikov s kroničnim hipoparirusom, ki jih s standardno terapijo ni mogoče ustrezno nadzorovati.
vipidia
takeda pharma a/s - alogliptin - diabetes mellitus, tip 2 - drugs used in diabetes, dipeptidyl peptidase 4 (dpp-4) inhibitors - vipidia je navedeno pri odraslih, starih 18 let in starejši s sladkorno boleznijo tipa 2 za izboljšanje nadzora glycaemic v kombinaciji z drugimi glukoze, zniževanje zdravila, vključno z insulinom, ko ti, skupaj z dieto in telesno vadbo, ne zagotavljajo ustrezne glycaemic nadzor (glej točki 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedem, dedno - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
alunbrig
takeda pharma a/s - brigatinib - karcinom, pljučni pljuč - antineoplastična sredstva - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
feiba 25 e./ml prašek in vehikel za raztopino za infundiranje
baxalta innovations gmbh - zaviralci inhibitorjev faktorja viii - prašek in vehikel za raztopino za infundiranje - zaviralci inhibitorjev faktorja viii 500 e. / 1 viala - zaviralci inhibitorjev faktorja viii